Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

CBLL

Ceribell Inc.

Oct 23 • 10:19AM ET

26.42

Dollar change +0.07
Percentage change 0.27	%

Healthcare • Medical Devices • USA • NASD

Index	-	P/E	-	EPS (ttm)	-	Insider Own	61.51%	Shs Outstand	34.02M	Perf Week	-0.04%
Market Cap	898.81M	Forward P/E	-	EPS next Y	-	Insider Trans	3.04%	Shs Float	13.09M	Perf Month	-
Income	-	PEG	-	EPS next Q	-	Inst Own	29.61%	Short Float	-	Perf Quarter	-
Sales	-	P/S	-	EPS this Y	-	Inst Trans	-	Short Ratio	-	Perf Half Y	-
Book/sh	-	P/B	-	EPS next Y	-	ROA	-	Short Interest	-	Perf Year	-
Cash/sh	-	P/C	-	EPS next 5Y	-	ROE	-	52W Range	23.00 - 27.71	Perf YTD	5.68%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-	ROI	-	52W High	-4.66%	Beta	-
Dividend TTM	-	Quick Ratio	-	Sales past 5Y	74.47%	Gross Margin	-	52W Low	14.87%	ATR (14)	1.44
Dividend Ex-Date	-	Current Ratio	-	EPS Y/Y TTM	-	Oper. Margin	-	RSI (14)	-	Volatility	4.95% -
Employees	229	Debt/Eq	-	Sales Y/Y TTM	-	Profit Margin	-	Recom	-	Target Price	-
Option/Short	No / Yes	LT Debt/Eq	-	EPS Q/Q	-	Payout	-	Rel Volume	0.04	Prev Close	26.35
Sales Surprise	-	EPS Surprise	-	Sales Q/Q	-	Earnings	-	Avg Volume	843.64K	Price	26.42
SMA20	0.99%	SMA50	0.99%	SMA200	0.99%	Trades		Volume	5,844	Change	0.27%

Oct-18-24 01:01AM	TPG GP A, LLC Acquires New Stake in CeriBell Inc (GuruFocus.com)
Oct-16-24 04:05PM	New Clinical Evidence Links Ceribell Point-of-Care EEG to Shorter Hospital Stays and Better Functional Outcomes Compared to Conventional EEG (PR Newswire)
Oct-15-24 05:00PM	CeriBell, Inc. Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares (PR Newswire)
Oct-14-24 06:45AM	Opening Day: Another trio of biotech IPOs make Friday debut (TipRanks)
Oct-11-24 05:00PM	CeriBell Shares Rise 47% to Lead Trio of Life Sciences IPOs (Bloomberg)
10:15AM	Loading…
10:15AM	CeriBell IPO: Stock price soars as AI brain-monitoring headband maker debuts on Nasdaq (FastCompany)
08:45AM	Upstream Bio Leads Life Sciences IPOs With Upsized Listing (Bloomberg)
Oct-10-24 11:27PM	CeriBell, Inc. Announces Pricing of Upsized Initial Public Offering (PR Newswire)

Ceribell, Inc. is a commercial-stage medical technology company, which focuses on transforming the diagnosis and management of patients with serious neurological conditions. Its products include Point-of-Care EEG, which enables early detection and management of suspected seizure patients, promoting precise patient care and hospital-wide efficiencies, Clarity, an AI algorithm that interprets EEG in real-time, providing bedside alerts and continuous monitoring for status epilepticus, and EEG Portal, which makes it easy to remotely review EEG in real-time with pre-annotated EEG insights. The company was founded by Xing Juan Chao, Josef Parvizi, and Chris Chafe on August 29, 2014 and is headquartered in Sunnyvale, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
TPG GP A, LLC	10% Owner	Oct 15 '24	Buy	17.00	380,268	6,464,556	3,967,422	Oct 17 04:14 PM
Tammenoms Bakker Juliet	Director	Oct 15 '24	Buy	17.00	237,234	4,032,978	2,475,110	Oct 16 04:18 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

CBLL

Ceribell Inc.

Upgrade your FINVIZ experience